Kelly Hunter; Senior Manager, Regulatory Affairs at Orthocell.
“Touch-town in the stunning Queenstown ! I am very excited to be facilitating the session on Regulatory Compliance post phase II studies at the first ever ANZ Cell and Gene Therapy Manufacturing workshop. I will also be sharing some valuable insights from Orthocell Ltd 's journey from end to end, with the successful development and regulatory approval of our cartilage cell therapy (OrthoACI) and discuss our future plans for commercialisation of the first-ever injectable cell therapy for treatment of chronic tendon injuries (OrthoATI) in Australia and the US.”
Kelly Hunter; Senior Manager, Regulatory Affairs at Orthocell....
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.5¢ | $64.05K | 168.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90080 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 47873 | 3 |
View Market Depth
| Last trade - 15.42pm 08/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |